PetMeds Granted Equity Awards to New Executives

The Delray Beach-based company issued stock packages to two newly hired leaders as an employment inducement.

Updated on Oct. 2, 2026 in People

Isometric editorial illustration of a metal balance scale on a geometric plinth, representing corporate executive compensation.
PetMeds has issued equity award packages to two incoming executives as part of its newly adopted 2024 Inducement Incentive Plan. AI Illustration. Upload story photo >

PetMeds has granted equity awards to two new executives to serve as material inducements for their employment. The compensation packages include restricted common stock and performance share units for the incoming leadership.

Why it matters

The grants follow the company’s adoption of the 2024 Inducement Incentive Plan, which allows for these stock awards to attract talent. This mechanism is a standard practice for corporations to align executive incentives with long-term performance targets.

PetMeds awarded Jeff Willard 250,000 shares of restricted stock and 250,000 performance units, while Andrew Parry received 100,000 restricted shares. These grants, authorized under Nasdaq Listing Rule 5635(c)(4), vest over three years.

The players

PetMeds

A Delray Beach-based company that operates as a pet pharmacy.

Jeff Willard

An incoming executive who received a grant of 500,000 total shares.

Andrew Parry

A newly hired executive awarded 100,000 restricted shares of common stock.

The details

The board approved these equity packages to secure the talent required for the company's strategic goals. The performance share units for Jeff Willard are tied to a three-year period that concludes in late 2029.

Timeline

  1. September 2024: The 2024 Inducement Incentive Plan was adopted.

  2. September 2026: The 2024 Inducement Incentive Plan was amended.

  3. September 28, 2026: Equity awards were granted to Jeff Willard.

  4. October 1, 2026: Equity awards were granted to Andrew Parry.

  5. September 27, 2029: The performance share unit period concludes.

Market Landscape

The use of inducement plans under Nasdaq Listing Rule 5635(c)(4) reflects a broader trend of companies leveraging equity to attract specialized leadership. This approach keeps the firm competitive within the executive talent market while preserving cash resources for operational expansion.

While these grants change the equity structure of the company, they do not directly alter consumer pricing or service availability for pharmacy customers. Shoppers should anticipate continued operations under the newly appointed leadership team.

The takeaway

Companies frequently use restricted stock awards to incentivize incoming leadership to focus on long-term corporate growth. These packages demonstrate how firms balance current hiring needs with future financial performance metrics.

Further reading

For more information on executive movements and corporate leadership shifts, visit the People section.